findmyKOL
Clinical trialNCT04905017RecruitingInterventional

Trisol System EFS Study

SponsorTrisol MedicalEnrollment30Tricuspid Regurgitation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this early feasibility study is to gain early clinical insight into Trisol system safety and performance to treat patients with moderate or greater tricuspid regurgitation (TR).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cedars-Sinai Medical Center

    Los Angeles, California, United States

    Rajendra Makkar, MD
    Recruiting
  • Piedmont Heart Institute

    Atlanta, Georgia, United States

    Pradeep K Yadav, MDVinod Thourani, MD
    Recruiting
  • Columbia University Medical Center/nyph

    New York, New York, United States

    Recruiting
  • Cleveland Clinic

    Cleveland, Ohio, United States

    Amar Krishnaswamy, MD
    Recruiting
  • Main Line Health / Lankenau Institute for Medical Research

    Wynnewood, Pennsylvania, United States

    William Gray, MD FACC FSCAI
    Not, yet, recruiting
  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

    Kashish Goel, MD
    Recruiting
  • University of Virginia Cardiology

    Charlottesville, Virginia, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Mar 2022
Primary completion
1 Jan 2026
Completion
1 Jul 2031
Last update posted
21 Nov 2025
Registered enrollment
30
Registry id
NCT04905017

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.